
Michael Thanh Tran
Examiner (ID: 128, Phone: (571)272-1795 , Office: P/2827 )
| Most Active Art Unit | 2827 |
| Art Unit(s) | 2818, 2511, 2827 |
| Total Applications | 3169 |
| Issued Applications | 2956 |
| Pending Applications | 141 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12231902
[patent_doc_number] => 20180064765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'LISTERIA-BASED IMMUNOGENIC COMPOSITIONS FOR ELICITING ANTI-TUMOR RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 15/326011
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 31780
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326011
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326011 | LISTERIA-BASED IMMUNOGENIC COMPOSITIONS FOR ELICITING ANTI-TUMOR RESPONSES | Jul 16, 2015 | Abandoned |
Array
(
[id] => 13325987
[patent_doc_number] => 20180214531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => MENINGOCOCCUS VACCINES
[patent_app_type] => utility
[patent_app_number] => 15/319665
[patent_app_country] => US
[patent_app_date] => 2015-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319665 | Meningococcus vaccines | Jul 15, 2015 | Issued |
Array
(
[id] => 10662310
[patent_doc_number] => 20160008450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'COMPOSITIONS PRODUCED USING ENTERIC PATHOGENS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/798726
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 42032
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798726
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798726 | Compositions produced using enteric pathogens and methods of use | Jul 13, 2015 | Issued |
Array
(
[id] => 10474891
[patent_doc_number] => 20150359909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'ORALLY ADMINISTERED BACTERIA AS VEHICLES FOR SYSTEMIC DELIVERY OF AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/799154
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11751
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14799154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/799154 | ORALLY ADMINISTERED BACTERIA AS VEHICLES FOR SYSTEMIC DELIVERY OF AGENTS | Jul 13, 2015 | Abandoned |
Array
(
[id] => 11618359
[patent_doc_number] => 20170128546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'Therapeutic Charge Engineered Variants of Lysozyme and Methods for Using Same to Treat Infections'
[patent_app_type] => utility
[patent_app_number] => 14/791979
[patent_app_country] => US
[patent_app_date] => 2015-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13792
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14791979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/791979 | Therapeutic charge engineered variants of lysozyme and methods for using same to treat infections | Jul 5, 2015 | Issued |
Array
(
[id] => 10705511
[patent_doc_number] => 20160051658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'NEISSERIAL ANTIGENIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/750837
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19085
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14750837
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/750837 | NEISSERIAL ANTIGENIC PEPTIDES | Jun 24, 2015 | Abandoned |
Array
(
[id] => 10399440
[patent_doc_number] => 20150284449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'H. PYLORI LIPOPOLYSACCHARIDE OUTER CORE EPITOPE'
[patent_app_type] => utility
[patent_app_number] => 14/739013
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17266
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14739013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/739013 | H. pylori lipopolysaccharide outer core epitope | Jun 14, 2015 | Issued |
Array
(
[id] => 11588495
[patent_doc_number] => 20170112907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT'
[patent_app_type] => utility
[patent_app_number] => 15/317261
[patent_app_country] => US
[patent_app_date] => 2015-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7681
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317261
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317261 | NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT | Jun 11, 2015 | Abandoned |
Array
(
[id] => 10453390
[patent_doc_number] => 20150338406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'IMMUNOREACTIVE GLYCOPROTEIN GP19 OF EHRLICHIA CANIS'
[patent_app_type] => utility
[patent_app_number] => 14/729758
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 45441
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729758
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729758 | Immunoreactive glycoprotein GP19 of ehrlichia canis | Jun 2, 2015 | Issued |
Array
(
[id] => 11728015
[patent_doc_number] => 20170189458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'LACTIC ACID BACTERIAL IMMUNOPOTENTIATING ACTIVITY-INCREASING COMPOSITION AND METHOD FOR INCREASING IMMUNOPOTENTIATING ACTIVITY OF LACTIC ACID BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/314149
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9815
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314149
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314149 | Lactic acid bacterial immunopotentiating activity-increasing composition and method for increasing immunopotentiating activity of lactic acid bacteria | May 28, 2015 | Issued |
Array
(
[id] => 11521650
[patent_doc_number] => 09605036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Vaccines and diagnostics for the ehrlichioses'
[patent_app_type] => utility
[patent_app_number] => 14/724136
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 40010
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724136
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724136 | Vaccines and diagnostics for the ehrlichioses | May 27, 2015 | Issued |
Array
(
[id] => 11834655
[patent_doc_number] => 20170216375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Neonatal Microbiome Supplementation'
[patent_app_type] => utility
[patent_app_number] => 15/312465
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9476
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312465
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312465 | Neonatal Microbiome Supplementation | May 19, 2015 | Abandoned |
Array
(
[id] => 10428965
[patent_doc_number] => 20150313976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'PRION EPITOPES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/709877
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20293
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709877
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/709877 | Prion epitopes and methods of use thereof | May 11, 2015 | Issued |
Array
(
[id] => 10437396
[patent_doc_number] => 20150322409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'METHOD FOR PREVENTION AND TREATMENT OF ESCHERICHIA COLI INFECTIONS USING A BACTERIOPHAGE WITH BROAD ANTIBACTERIAL SPECTRUM AGAINST ESCHERICHIA COLI'
[patent_app_type] => utility
[patent_app_number] => 14/706325
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5898
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706325
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706325 | Method for prevention and treatment of Escherichia coli infections using a bacteriophage with broad antibacterial spectrum against Escherichia coli | May 6, 2015 | Issued |
Array
(
[id] => 12428925
[patent_doc_number] => 09976149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-22
[patent_title] => Modified listeria bacteria and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/706178
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 17
[patent_no_of_words] => 24778
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706178 | Modified listeria bacteria and uses thereof | May 6, 2015 | Issued |
Array
(
[id] => 13220575
[patent_doc_number] => 10124048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Adenovirus vectors
[patent_app_type] => utility
[patent_app_number] => 14/697373
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 14590
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14697373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/697373 | Adenovirus vectors | Apr 26, 2015 | Issued |
Array
(
[id] => 11441927
[patent_doc_number] => 20170042948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT'
[patent_app_type] => utility
[patent_app_number] => 15/305496
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10872
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305496
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305496 | Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract | Apr 22, 2015 | Issued |
Array
(
[id] => 13636785
[patent_doc_number] => 09845349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Regulating Bacillus anthracis lethal factor activity via an activating epitope region
[patent_app_type] => utility
[patent_app_number] => 14/694627
[patent_app_country] => US
[patent_app_date] => 2015-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 16789
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694627
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/694627 | Regulating Bacillus anthracis lethal factor activity via an activating epitope region | Apr 22, 2015 | Issued |
Array
(
[id] => 10405303
[patent_doc_number] => 20150290312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'GNA1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis'
[patent_app_type] => utility
[patent_app_number] => 14/688594
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 28017
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/688594 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Apr 15, 2015 | Issued |
Array
(
[id] => 11436065
[patent_doc_number] => 20170037087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'GROUP A STREPTOCOCCUS VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/304462
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12507
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304462 | Group A | Apr 14, 2015 | Issued |